Literature DB >> 21705949

Serotonin-producing enterochromaffin cell tumors of the pancreas: clinicopathologic study of 15 cases and comparison with intestinal enterochromaffin cell tumors.

Stefano La Rosa1, Francesca Franzi, Luca Albarello, Anja Schmitt, Barbara Bernasconi, Maria Grazia Tibiletti, Giovanna Finzi, Claudia Placidi, Aurel Perren, Carlo Capella.   

Abstract

OBJECTIVES: Serotonin-producing tumors of the pancreas are rare endocrine neoplasms composed of enterochromaffin (EC) cells that have been mainly described in the literature as case reports. This study analyzes the clinicopathologic features of a series of pancreatic EC cell neoplasms and their similarities to and differences from intestinal EC cell tumors.
METHODS: The morphological, immunohistochemical, ultrastructural, and fluorescent in situ hybridization features of 15 pancreatic and 20 intestinal serotonin-producing neoplasms were compared. In addition, we reviewed the literature on pancreatic serotonin-producing tumors to better understand the clinicopathologic features of this rare tumor type.
RESULTS: The lack of substance P and acidic fibroblast growth factor immunoreactivity; the low immunohistochemical expression of CDX2, vesicular monoamine transporter 1, connective tissue growth factor, and prostatic acid phosphatase; the lack of S100-positive sustentacular cells; the strong expression of vesicular monoamine transporter 2; and peculiar ultrastructural features characterize pancreatic EC cell tumors and differentiate them from intestinal ones, although both categories show similar chromosome 18 cytogenetic alterations. The review of the literature indicates that pancreatic functioning tumors associated with the carcinoid syndrome arise in younger patients and are larger, more frequently malignant, and more aggressive neoplasms than pancreatic nonfunctioning ones.
CONCLUSIONS: Pancreatic EC cell tumors show several different morphological features compared with related intestinal tumors despite similar cytogenetic alterations on chromosome 18.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705949     DOI: 10.1097/MPA.0b013e31822041a9

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  11 in total

Review 1.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

Review 2.  Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.

Authors:  Alfred King-Yin Lam; Hirotaka Ishida
Journal:  Histol Histopathol       Date:  2020-12-11       Impact factor: 2.303

3.  Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement.

Authors:  Chad M McCall; Chanjuan Shi; Alison P Klein; Björn Konukiewitz; Barish H Edil; Trevor A Ellison; Christopher L Wolfgang; Richard D Schulick; Günter Klöppel; Ralph H Hruban
Journal:  Hum Pathol       Date:  2012-01-04       Impact factor: 3.466

4.  Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review.

Authors:  Nikolaos Zavras; Demetrios Schizas; Nikolaos Machairas; Vasileia Damaskou; Nikolaos Economopoulos; Anastasios Machairas
Journal:  Oncol Lett       Date:  2017-02-06       Impact factor: 2.967

5.  Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.

Authors:  Marianne E Pavel; Alexandria T Phan; Edward M Wolin; Beloo Mirakhur; Nilani Liyanage; Susan Pitman Lowenthal; George A Fisher; Aaron I Vinik
Journal:  Oncologist       Date:  2018-10-24

6.  National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors.

Authors:  Gyulnara G Kasumova; Omidreza Tabatabaie; Mariam F Eskander; Abhishek Tadikonda; Sing Chau Ng; Jennifer F Tseng
Journal:  J Am Coll Surg       Date:  2016-12-10       Impact factor: 6.113

7.  The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.

Authors:  Jamie Koo; Xiaoyan Zhou; Elizabeth Moschiano; Mariza De Peralta-Venturina; Richard B Mertens; Deepti Dhall
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

8.  Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.

Authors:  Mark Kidd; Irvin M Modlin; Ignat Drozdov
Journal:  BMC Genomics       Date:  2014-07-15       Impact factor: 3.969

Review 9.  Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.

Authors:  Nikolaos Tsoukalas; Eleftherios Chatzellis; Dimitra Rontogianni; Krystallenia I Alexandraki; Georgios Boutzios; Anna Angelousi; Gregory Kaltsas
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

10.  Serotonin-Secreting Neuroendocrine Tumours of the Pancreas.

Authors:  Anna Caterina Milanetto; Matteo Fassan; Alina David; Claudio Pasquali
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.